Explore the design and findings from a preliminary study that found no health or development impacts during the first 3 years of life among infants who were exposed to monoclonal antibodies through breast milk.
Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
When taken while breastfeeding, monoclonal antibodies may not impact the health or development of infants. Dive into the findings.
Media formats available:
Overview
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!